Full Coverage

Aveo granted patent for genetic screen technology

May 24, 2008
Story Timeline:  195 days

Aveo Pharmaceuticals has announced that the US Patent and Trademark Office has granted patent covering the company's mammalian second site suppressor screen technology for identifying small molecule and antibody targets functionally relevant to cancer cell proliferation and survival. [read full story]                    

Add Comment
Latest article on this story:

Aveo Pharma gets patent for genetic screen

pharmiweb.co.uk May 27, 2008
First article on this story:

Aveo Pharma gets patent for genetic screen

pharmiweb.co.uk May 27, 2008
Selected publications with coverage of this story:
RELATED